Multiple sclerosis in sibling pairs: an analysis of 250 families
Open accessAbstract
OBJECTIVES: To assess the potential contribution of genetic factors to clinical phenotype in multiple sclerosis. METHODS: Using a cohort of 262 pairs of coaffected siblings from 250 families with multiple sclerosis, intersibling concordance analysis was used to explore underlying genetic mechanisms in disease pathogenesis by assessing parameters of disease course, clinical presentation, age and year of onset, and measures of disability and handicap. RESULTS: Adjusted intraclass correlation coefficients were not significant for either age of onset or for year of first symptom. One third of sibling pairs were concordant for presenting symptom (81/262), a result that was non-significant. However, course type was identical in 50% of the sibling pairs (kappa=0.17 (95% confidence interval (95% CI) 0.08 to 0.26)) indicating a significant result. Severity of the disease at assessment, using the Kurtzke and CAMBS scales, demonstrated that whereas there was no agreement for relapse rate in the previous year within the sibship, there was significant concordance for measures of disability (kappa=0.11 (95% CI 0.04 to 0.19)), progression (kappa=0.09 (95% CI 0.01 to 0.18)) and handicap (kappa=0.08 (95% CI 0.02 to 0.14)). CONCLUSIONS: Within a sibship, the clinical presentation tends to be different. However, once established, concordance is more likely to be seen for the ultimate course, leading in the end to similar disability and handicap scores. These results are consistent with the hypothesis that genes influence both disease susceptibility and evolution in multiple sclerosis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
An independent genetic architecture determines the clinical course of MS.
“These findings, together with the concordance for outcome within families7, suggest that an independent genetic architecture determines the clinical course of the disease”
From Locus for severity implicates CNS resilience in progression of multiple sclerosis (2023) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A genome-wide search for human type 1 diabetes susceptibility genes
Davies, J. L., Kawaguchi, Y., Bennett, S. T., Copeman, J. B., Cordell, H. J., Pritchard, L. E., Reed, P. W., Gough, S. C. L., Jenkins, S. C., Palmer, S. M., et al. (1994) · Nature · doi:10.1038/371130a0 · Cited by 1,276 · see citing works
Flagged first, then by citations
Research works printed but not linked: 29
- Sadovnick AD, Armstrong H, Rice GPA, et al. A poulation based study of multiple sclerosis in twins: updated. Ann Neurol 1993;33:281-5.
- Mumford CJ, Wood NW, Kellar-Wood HF, et al. The Brit- ish Isles survey of multiple sclerosis in twins. Neurology 1994;44:11-15.
- Sadovnick AD, Ebers GC, Dyment DA, et al. Evidence for genetic basis of multiple sclerosis. Lancet 1996;347:1728- 31.
- Robertson NP, Fraser M, Deans J, et al. Age adjusted recur- rence risks for relatives of patients with multiple sclerosis. Brain 1996;119:449-55.
- Robertson NP, O'Riordan JI, Chataway J, et al. OVspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet 1997;349:1587-90.
- Daniels SE, Bhattacharrya S, James A, et al. A genome-wide search for quantitative trait loci underlying asthma. Nature 1996;383:247-50.
- Satsangi J, Parkes M, Louis E, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996;14:199-202.
- Sawcer SJ, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromo- somes 6p21 and 17q22. Nat Genet 1996;13:464-8.
- Ebers GC, Kukay K, Bulman DE, et al. A full genome search in multiple sclerosis. Nat Genet 1996;13:472-6.
- Haines JL, Ter-Minassian M, Bazyk A, et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genetics 1996;13:469-71.
- Kuokkanen S, Gschwend M, Rioux JD, et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997;61:1379-87.
- Chataway J, Feakes R, Coraddu F, et al. The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 1998;121:1869-87.
- Coraddu F, Sawcer S, Feakes R, et al. HLA typing in the United Kingdom multiple sclerosis genome screen. Neuro- genetics 1998;2:24-33.
- Robertson NP, Clayton D, Fraser MA, et al. Clinical concordance in sibling pairs with multiple sclerosis. Neurol- ogy 1996;47:347-52.
- Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research proto- cols. Ann Neurol 1983;13:227-31.
- Chataway J, Sawcer S, Coraddu F, et al. Evidence that allelic variants of the spinocerebellar ataxia type 2 gene influence susceptibility to multiple sclerosis. Neurogenetics 1999;2: 91-6.
- Confraveux C, Compston DHR, Hommes OR, et al. EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry 1992;55:671-6.
- Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability scale status. Neurology 1983;33:1444-52.
- Mumford CJ, Compston A. Problems with rating scales for multiple sclerosis: a novel approach: the CAMBS score. J Neurol 1993;240:209-15.
- Fleiss JL. Statistical methods for rates and proportions. New York: Wiley, 1981.
- Mander AP, Chataway J, Clayton DG, et al. Estimation of agreement in the presence of confounders. Annals of Human Genetics (submitted).
- Curtius F, Speer H. Multiple Sklerose und Erbanlagen II Mittelung. Zeitschrift für die gesamte Neurologie und Psychi- atrie 1937;160:226-45.
- Roberts DF, Roberts MJ, Poskanzer DC. Genetic analysis of multiple sclerosis in Orkney. J Epidemiol Community Health 1979;33:229-35.
- Bulman DE, Sadovnick AD, Ebers GC. Age of onset in sib- ling pairs concordant for multiple sclerosis. Brain 1991; 114:937-50.
- Doolittle TH, Myers RH, Lehrich JR, et al. Multiple sclero- sis sibling pairs: clustered onset and familial predisposition. Neurology 1990;40:1546-52.
- French Research Group for Multiple Sclerosis. Familial fac- tors influence disability in MS multiplex families. Neurology 1999;52:1632-6.
- Schapira K, Poskanzer DC, Miller H. Familial and conjugal multiple sclerosis. Brain 1963;86:315-32.
- Weinshenker B, Armstrong H, Bulman D. A comparison of familial and sporadic MS. Can J Neurol Sci 1986;13:168.
- American Multiple Sclerosis Group. Clinical demographics of multiplex families with multiple sclerosis. Ann Neurol 1998;43:530-4.
Cited by
Sorted by citations
Lee, J. C., Biasci, D., Roberts, R., Gearry, R. B., Mansfield, J. C., Ahmad, T., Prescott, N. J., Satsangi, J., Wilson, D. C., Jostins, L., et al. (2017) · Nature Genetics · doi:10.1038/ng.3755 · Cited by 304 · see citing works
Paternoster, L., Tilling, K., & Davey Smith, G. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006944 · Cited by 271 · see citing works
Locus for severity implicates CNS resilience in progression of multiple sclerosis
International Multiple Sclerosis Genetics Consortium, Harroud, A., Stridh, P., McCauley, J. L., Saarela, J., van den Bosch, A. M. R., Engelenburg, H. J., Beecham, A. H., Alfredsson, L., Alikhani, K., et al. (2023) · Nature · doi:10.1038/s41586-023-06250-x · Cited by 243 · see citing works
Inflammation in multiple sclerosis: the good, the bad, and the complex
Martino, G., Adorini, L., Rieckmann, P., Hillert, J., Kallmann, B., Comi, G., & Filippi, M. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00223-5 · Cited by 142 · see citing works
Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis
Ramagopalan, S. V., Cukjati, M., Černilec, M., DeLuca, G. C., Dyment, D. A., Degenhardt, A., Sadovnick, A. D., Šerbec, V. Č., Ebers, G. C., & Duquette, P. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.036 · Cited by 16 · see citing works
- Authors
- Chataway, J.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Chataway, J
- ORCID
- Chataway, J
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2001-12-01
- Volume
- 71
- Issue
- 6
- Pages
- 757-761
- ISSN
- 0022-3050 (ISSN-L)
- PMC
- PMC1737661
- OpenAlex
- W2081253606
- Cited by
- 53
- References
- 1
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 1 · 2015: 2 · 2014: 1 · 2012: 2
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Griffith Research Online (submittedVersion)
- Funders
- Wellcome Trust
- Multiple Sclerosis Society
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, genetic susceptibility, concordance, sibling pairs, clinical course, disability, handicap, age of onset, clinical phenotype, disease progression, relapse rate
- MeSH terms
- Activities of Daily Living, Analysis of Variance, Female, Genetic Testing, United Kingdom, Disabled Persons, Persons with Disabilities, Humans, Male, Pedigree, Registries, Severity of Illness Index, Time Factors, Cohort Studies, Confounding Factors, Epidemiologic, Age of Onset, Disease Progression, Genetic Predisposition to Disease, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review